- Acetarsone
- Acetarsone diethylamine salt
- 97-45-02-Cyclohexen-1-ol,2-methyl-5-(1-methylethenyl)-, 1-propanoate
- 97452-63-61,3-Benzenediol,5-(1,1-dimethylheptyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-
- 97456-49-0Cycloart-22-ene-3,25-diol
- 97458-54-3Acetamide,2-bromo-N-[4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenyl]-
- 97458-57-6Acetamide,2-bromo-N-[4-[2-[[2-hydroxy-3-[[1-(iodo-125I)-9H-carbazol-4-yl]oxy]propyl]amino]-2-methylpropyl]phenyl]-(9CI)
- 97465-82-25-O-Methylhierochin D
- 97466-49-4Oxirane,2-(4-chlorophenyl)-, (2S)-
- 97467-72-6Hexanoic acid,3,5,5-trimethyl-, 2-hydroxy-1,3-propanediyl ester (9CI)
- 97468-37-6Cephapirin benzathine
- 97474-88-9L-Cysteine,L-cysteinyl-L-histidyl-L-serylglycyl-L-tyrosyl-L-valylglycyl-L-valyl-L-arginyl-,cyclic (1®10)-disulfide (9CI)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Acetarsone |
EINECS | N/A |
| CAS No. | 97-44-9 | Density | g/cm3 |
| PSA | 106.86000 | LogP | -1.01540 |
| Solubility | N/A | Melting Point |
220.5°C |
| Formula | C8H10 As N O5 | Boiling Point | °Cat760mmHg |
| Molecular Weight | 275.093 | Flash Point | °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion and intravenous routes. Human systemic effects by ingestion: respiratory system, endocrine system, dermatitis, and fever. Human systemic effects by intravaginal route: hallucinations, distorted perceptions, convulsions, nausea or vomiting, decreased urine volume, and fever. Mutation data reported. See also ARSENIC COMPOUNDS. When heated to decomposition it emits very toxic fumes of NOx and As. | Risk Codes | 23/25-50/53 |
| Molecular Structure |
|
Hazard Symbols |
 
|
| Synonyms |
Arsonicacid, [3-(acetylamino)-4-hydroxyphenyl]- (9CI); m-Arsanilic acid,N-acetyl-4-hydroxy- (7CI,8CI); 190F; 3-Acetamido-4-hydroxybenzenearsonic acid;3-Acetamido-4-hydroxyphenylarsonic acid;3-Acetylamino-4-hydroxyphenyl-1-arsonic acid;3-Acetylamino-4-hydroxyphenylarsonic acid; Acetarsol; Acetarsone;Acetphenarsine; Amarsan; Amoebal; Arsaphen; Arsonine; Chrlich 594; Devegan;Disparicida; Dynarsan; Ehrlich 594; F 190; Fourneau 190; Ginarsol; Goyl;Gynoplix; Kharophen; Kubarsol; Limarsol; Malagride; Mexyl; Monargan;N-Acetyl-4-hydroxy-m-arsanilic acid; NSC 13160; NSC 3247; Nilacid; Oralcid;Orarsan; Osarsal; Osarsol; Osarsole; Osvarsan; Pallicid; Paroxyl; SVC; Sanogyl;Spirocid; Spirozid; Stovarsol; Stovarsolan; Vagisept; Vagoflor |
Acetarsone Chemical Properties
Empirical Formula of Acetarsone (CAS NO.97-44-9): C8H10AsNO5
Molecular Weight: 275.0903 g/mol
EINECS: 202-582-3
Structure of Acetarsone (CAS NO.97-44-9):
IUPAC Name: (3-Acetamido-4-hydroxyphenyl)arsonic acid
Canonical SMILES: CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O
InChI: InChI=1S/C8H10AsNO5/c1-5(11)10-7-4-6(9(13,14)15)2-3-8(7)12/h2-4,12H,1H3,(H,10,11)(H2,13,14,15)
InChIKey: ODFJOVXVLFUVNQ-UHFFFAOYSA-N
Acetarsone Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LDLo | oral | 150mg/kg (150mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Proceedings of the Society for Experimental Biology and Medicine. Vol. 27, Pg. 267, 1930. |
| man | TDLo | oral | 89mg/kg/9D (89mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES ENDOCRINE: OTHER CHANGES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | American Journal of the Medical Sciences. Vol. 174, Pg. 819, 1927. |
| mouse | LD50 | intravenous | 180mg/kg (180mg/kg) | U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#03309, | |
| mouse | LD50 | oral | 4mg/kg (4mg/kg) | Compilation of LD50 Values of New Drugs. | |
| rabbit | LDLo | intravenous | 120mg/kg (120mg/kg) | Archives of Dermatology and Syphilology. Vol. 25, Pg. 799, 1932. | |
| rabbit | LDLo | oral | 125mg/kg (125mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Proceedings of the Society for Experimental Biology and Medicine. Vol. 27, Pg. 267, 1930. |
| rat | LDLo | intravenous | 300mg/kg (300mg/kg) | Archives of Dermatology and Syphilology. Vol. 25, Pg. 799, 1932. | |
| rat | LDLo | oral | 1200mg/kg (1200mg/kg) | British Journal of Pharmacology and Chemotherapy. Vol. 3, Pg. 44, 1948. | |
| women | LDLo | intravaginal | 155mg/kg/2D-I (155mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" GASTROINTESTINAL: NAUSEA OR VOMITING | British Medical Journal. Vol. 1, Pg. 1282, 1961. |
| women | LDLo | intravaginal | 1576mg/kg/2D- (1576mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED | British Medical Journal. Vol. 2, Pg. 242, 1960. |
| women | TDLo | oral | 86mg/kg/8D (86mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | American Journal of the Medical Sciences. Vol. 174, Pg. 819, 1927. |
Acetarsone Consensus Reports
ARSENIC and its compounds are on the Community Right-To-Know List.
Acetarsone Safety Profile
Poison by ingestion and intravenous routes. Human systemic effects by ingestion: respiratory system, endocrine system, dermatitis, and fever. Human systemic effects by intravaginal route: hallucinations, distorted perceptions, convulsions, nausea or vomiting, decreased urine volume, and fever. Mutation data reported. See also ARSENIC COMPOUNDS. When heated to decomposition it emits very toxic fumes of NOx and As.
Hazard Codes of Acetarsone (CAS NO.97-44-9): 
T,
N
Risk Statements: 23/25-50/53
R23/25:Toxic by inhalation and if swallowed.
R50/53:Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Safety Statements: 20/21-28-45-60-61
S20:When using, do not eat or drink.
S21:When using do not smoke.
S28:After contact with skin, wash immediately with plenty of soap-suds.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S60:This material and its container must be disposed of as hazardous waste.
S61:Avoid release to the environment. Refer to special instructions / safety data sheets.
Acetarsone Standards and Recommendations
OSHA PEL: TWA 500 µg(As)/m3
ACGIH TLV: BEI: 35 μ (As)/L inorganic ARSENIC and methylated metabolites in urine
Acetarsone Specification
Acetarsone , its cas register number is 97-44-9. It also can be called Acid Leather Acetarsol ; Acetamino-hydroxyphenyl-arsonsaeure ; and 3-Acetamido-4-hydroxy-phenylarsonic acid .
What can I do for you?
Get Best Price
